These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 23850258

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR, Kim HC, Kim SC.
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic factors of paraneoplastic pemphigus.
    Leger S, Picard D, Ingen-Housz-Oro S, Arnault JP, Aubin F, Carsuzaa F, Chaumentin G, Chevrant-Breton J, Chosidow O, Crickx B, D'incan M, Dandurand M, Debarbieux S, Delaporte E, Dereure O, Doutre MS, Guillet G, Jullien D, Kupfer I, Lacour JP, Leonard F, Lok C, Machet L, Martin L, Paul C, Pignon JM, Robert C, Thomas L, Weiller PJ, Ferranti V, Gilbert D, Courville P, Houivet E, Benichou J, Joly P.
    Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B.
    Eur J Dermatol; 2008 Oct; 18(2):159-64. PubMed ID: 18424375
    [Abstract] [Full Text] [Related]

  • 15. Rituximab and intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients.
    Brown AE, Motaparthi K, Hsu S.
    Dermatol Online J; 2018 Jan 19; 23(12):. PubMed ID: 29447653
    [Abstract] [Full Text] [Related]

  • 16. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz AR, Zakeri M.
    Ann Dermatol Venereol; 2002 Jan 19; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission.
    Strowd LC, Taylor SL, Jorizzo JL, Namazi MR.
    J Am Acad Dermatol; 2011 Mar 19; 64(3):490-4. PubMed ID: 20633956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.
    Reguiai Z, Tabary T, Maizières M, Bernard P.
    J Am Acad Dermatol; 2012 Oct 19; 67(4):623-9. PubMed ID: 22261417
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.